CV Sciences (CVSI) Revenue Growth (3y) (2016 - 2026)
CV Sciences (CVSI) Revenue Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 2.84% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 4.19% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 15.52% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 14.49% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 24.66% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 2.94% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -48.41% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 7.85% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 47.17% |
| 10 | CV Sciences | - | - | 1.56 Mn | -8.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.33% |
| Dec 31, 2025 | -5.10% |
| Sep 30, 2025 | -4.61% |
| Jun 30, 2025 | -4.36% |
| Mar 31, 2025 | -6.75% |
| Dec 31, 2024 | -7.88% |
| Sep 30, 2024 | -8.87% |
| Jun 30, 2024 | -8.30% |
| Mar 31, 2024 | -6.17% |
| Dec 31, 2023 | -9.91% |
| Sep 30, 2023 | -9.76% |
| Jun 30, 2023 | -9.75% |
| Mar 31, 2023 | -20.55% |
| Dec 31, 2022 | -25.42% |
| Sep 30, 2022 | -33.23% |
| Jun 30, 2022 | -37.38% |
| Mar 31, 2022 | -33.19% |
| Dec 31, 2021 | -29.57% |
| Sep 30, 2021 | -27.86% |
| Jun 30, 2021 | -25.39% |